DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories
02 1Polpharma
03 1Biophore India Pharmaceuticals Pvt Ltd
04 1LGM Pharma
05 1DKSH
06 1Chongqing Sintaho Pharmaceutical
07 1Tofigh Daru
08 1Chunghwa Chemical Synthesis & Biotech
09 1Omgene Life Sciences Pvt. Ltd
10 1TAPI Technology & API Services
11 1Allite (Shanghai) Pharmaceutical Technology
12 1Chongqing Carelife Pharmaceutical
13 1Chongqing Pharmaceutical Research Institute Co Ltd
14 1DEAFARMA
15 1Fresenius Kabi Oncology Limited
16 1Fujian South Pharmaceutical
17 1Guangzhou Tosun Pharmaceutical
18 1Hangzhou Longshine Bio-Tech
19 1Haoyuan Chemexpress Co.Ltd
20 1Hetero Drugs
21 1Hubei Honch Pharmaceutical
22 1Intas Pharmaceuticals
23 1Laurus Labs
24 1Lunan Pharmaceutical
25 1MSN Laboratories
26 1Mac-Chem Products (India) Pvt.Ltd
27 1Polymed Therapeutics Inc.
28 1Qilu Pharmaceutical
29 1SEACROSS PHARMACEUTICALS
30 1Sakar Healthcare
31 1Sichuan Huiyu Pharmaceutical
32 2Sionc Pharmaceuticals
33 1Sun-shine Chem
34 1Teva Pharmaceutical Industries
35 1Vannsh Life Sciences
36 1Viatris
37 1Yangtze River Pharmaceutical Group
01 14China
02 13India
03 1Iran
04 2Israel
05 1Italy
06 1Poland
07 1Switzerland
08 1Taiwan
09 3U.S.A
10 1United Kingdom
01 12Active
02 3Inactive
03 23Blank
01 38Blank
01 38Blank
01 1WC-0039
02 1WC-0115A3
03 1WC-0213
04 1WC-0273
05 1WC-0273A7
06 1WC-0349
07 32Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-07-06
Pay. Date : 2016-05-04
DMF Number : 30402
Submission : 2016-03-29
Status : Active
Type : II
Date of Issue : 2022-06-06
Valid Till : 2025-07-07
Written Confirmation Number : WC-0039
Address of the Firm :
NDC Package Code : 55111-985
Start Marketing Date : 2016-03-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-09-19
Pay. Date : 2024-08-27
DMF Number : 32406
Submission : 2017-12-30
Status : Active
Type : II
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Tofigh Daru develops & synthesizes a diverse range of APIs in Anticancer, Narcotics, Cardiovascular to Immunomodulatory Segments.
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31276
Submission : 2016-12-30
Status : Active
Type : II
NDC Package Code : 52076-6251
Start Marketing Date : 2012-10-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-02-25
Pay. Date : 2015-12-21
DMF Number : 30124
Submission : 2016-01-21
Status : Active
Type : II
We have 37 companies offering Carfilzomib
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?